PARTOW KEBRIAEI to Biomarkers, Tumor
This is a "connection" page, showing publications PARTOW KEBRIAEI has written about Biomarkers, Tumor.
Connection Strength
0.020
-
Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia. Acta Haematol. 2021; 144(1):74-81.
Score: 0.012
-
Pre-transplantation minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemia. Haematologica. 2017 01; 102(1):110-117.
Score: 0.009